OncoSwab, a biotechnology company focused on early detection of cancer through non-invasive molecular testing, today ...

Syantra, Inc., has recently completed new patent filings that expand previous work in cancer molecular diagnostics to encompass new drug targets and therapeutics.

Debates over AI antibody design terminology have clouded the industry’s shared mission of bringing better therapeutics to the ...

AI evolves beyond mere algorithms to open up new frontiers in generative AI and agentic AI, and the art of the possible is ...

Viva Biotech successfully held the AIDD platform launch event "Enchantment of Drug Discovery," unveiling the advanced and comprehensive AI-Driven Drug Discovery (AIDD) platform. During the event, Dr.

In RIT’s biotechnology bachelor’s degree you’ll develop technologies for genetics, agriculture, pharmaceuticals, vaccine development, energy/ environment, forensics, and more. Hands on Experience: ...

As of May 21, 2025, Anbio Biotechnology had a $342.4 million market capitalization, putting it in the 38th percentile of companies in the Biotechnology industry. Currently, Anbio Biotechnology’s price ...

This unexplored territory presents a major opportunity for AI to rapidly discover innovative detector designs more efficiently than humans can — opening new avenues for "listening" to the ...

remove-circle Internet Archive's in-browser video "theater" requires JavaScript to be enabled. It appears your browser does not have it turned on. Please see your ...

But there’s something else going on here. A recent New York Times piece details some of the new ideas MAGA pro-natalist thinkers are batting around as a way to goose the birth rate, and ...